Keywords: elderly polymedicated patients, medication review, digital platform
Introduction:
Elderly (>65) often receive polypharmacy, i.e. five drugs or more. Polypharmacy is a safety issue. Each new drug administered increases the risk of adverse events by 12-18%. Polypharmacy is also a public health, economic and ecologic issue.
Medication review (MR) is a systematic assessment of a patient's medication content and management, with the aim of optimising the quality of medication and minimising medication-related problems.
The MR can be carried out either in collaboration by the community pharmacist and the general practitioner, or by the doctor alone, or whith his trainee, or during a quality meeting.
MR is demanding and time consuming because it is necessary to answer several questions about the appropriateness of the indications and dosages, interactions, adverse events, possible underuse, overuse or misuse of each drug.
We have developed an online platform, ABIMED (Aide au Bilan de Medication), which aims to facilitate MR. The research is funded by the French National Research Agency,
ABIMED is a clinical decision support system, and relies on two knowledge bases, a national drug database and the STOPP & START v3 rules. ABIMED adopts a visual and integrated presentation of contextualized drug knowledge, adapted to the patient profile and the entire order.
Aim(s):
To discover and test the ABIMED platform.
To understand the benefits of a digital tool to facilitate MR.
Programme:
WHAT THE PARTICIPANTS WILL HAVE TO DO
Participants will work in small groups. They will have to do a MR of an elderly patient taking numerous medications, first without, then with, the help of ABIMED.
The groups will compare their experience and analyze the advantages and limitations of ABIMED. Participants will be able to describe the MR tools available in their own country.
EXPECTED RESULTS
Participants will have gained motivation to do MR. They will have understood the benefit of adopting ergonomic digital tools for visualizing and summarizing knowledge about medication.
#27
EQuiP is open to both Individual and Organizational Memberships. EQuiP offers a platform to improve the knowledge base and to improve closer collaboration between GPs / Family Doctors, researchers, educators, policy makers and organisations involved in quality and safety in family medicine and primary care.
